BLACK DIAMOND THERAPEUTICS, INC. Current Assets
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Current Assets of $115.39 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-05
- 2026-06-30: Assets, Current $115.39M.
- 2026-03-31: Assets, Current $122.97M.
- 2025-12-31: Assets, Current $132.44M.
- 2025-09-30: Assets, Current $138.99M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $115.39M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $122.97M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $132.44M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $138.99M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $146.73M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $155.68M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $101.18M 10-K · filed 2026-03-16 |
| 2024-09-30 | $115.54M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $126.75M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $118.81M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $134.03M 10-K · filed 2025-03-06 |
| 2023-09-30 | $147.05M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $92.99M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $107.98M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $127.71M 10-K · filed 2024-03-12 |
| 2022-09-30 | $150.98M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $168.56M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $188.30M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $215.70M 10-K · filed 2023-03-09 |
| 2021-09-30 | $241.55M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $270.95M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $297.35M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $319.55M 10-K · filed 2022-03-17 |
| 2020-09-30 | $336.43M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $208.25M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $362.09M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $155.71M 10-K · filed 2021-03-25 |
| 2018-12-31 | $51.68M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |